CEACAM1 and malignant colon neoplasm: NE within NETs can be targeted with a NE inhibitor and CEACAM1 with a CEACAM1 monoclonal antibody, where both have been found to reduce metastasis in colonic cancer cells, with a synergistic effect when used in combination (41).